The Federal Register http://thefederalregister.com/b.p/department/DEPARTMENT_OF_JUSTICE/2006-12-22/ Daily Publications of Meetings and Rules Changes for the Federal Government Fri, Dec 5 2008 11:00:00 GMT Fri, Dec 5 2008 11:00:00 GMT info@thefederalregister.com <![CDATA[ Notice Pursuant to the National Cooperative Research and Production Act of 1993--Institute of Electrical and]]> http://thefederalregister.com/d.p/2006-12-22-06-9832

Notice is hereby given that, on November 9, 2006, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (``the Act''), Institute of Electrical and Electronics Engineers (``IEEE'') has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing additions or changes to its standards development activities. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, five new standards have been initiated and five existing standards are being revised. More detail regarding these changes can be found at http://standards.ieee.org/standardswire/sba/110206.html .

On September 17, 2004, IEEE filed its original ]]> http://thefederalregister.com/d.p/2006-12-22-06-9832 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Notice Pursuant to the National Cooperative Research and Production Act of 1993--Power Tool Institute Table Saw]]> http://thefederalregister.com/d.p/2006-12-22-C6-9644

In notice document 069644 beginning on page 74559 in the issue of Tuesday, December 12, 2006, make the following corrections:

1. On page 74559, in the third column, in the last paragraph, in the second line, ``november 2'' should read ``November 2''.

2. On the same page, in the same column, in the last paragraph, in the last line, ``national Cooperative'' should read ``National Cooperative''.

3, On page 74560, in the first column, in the first full paragraph, in the sixth line, ``mount Prospect'' should read ``Mount Prospect''. [FR Doc. C69644 Filed 122106; 8:45 am]
BILLING CODE 150501D ]]> http://thefederalregister.com/d.p/2006-12-22-C6-9644 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Notice Pursuant to the National Cooperative Research and Production Act of 1993--Tree Care Industry Association, Inc.]]> http://thefederalregister.com/d.p/2006-12-22-06-9833

Notice is hereby given that, on November 27, 2006, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (``the Act''), Tree Care Industry Association, Inc. (``TCIA'') has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing additions or changes to its standards development [[Page 77062]]
activities. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, TCIA recently finalized and adopted four standards: BSR A300 Part 5 Management of Trees and ShrubsStandard Practices (Management of Trees and Shrubs During Site Planning, Site Development, and Construction); BSR A300 Part 6 Transplanting; PINS A300 Part 7 Integrated Vegetation Management; and TCIA Accreditation Council Standards for Accreditation Draft 5 Version 2.

On September 8, 2004, TCI ]]> http://thefederalregister.com/d.p/2006-12-22-06-9833 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-22-E6-21880

By Notice dated August 15, 2006, and published in the Federal Register on August 22, 2006, (71 FR 48944), Aldrich Chemical Company, Inc., DBA Isotec, 3858 Benner Road, Miamisburg, Ohio 453424304, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Cathinone (1235)........................... I
Methcathinone (1237)....................... I
NEthylamphetamine (1475).................. I
N,NDimethylamphetamine (1480)............. I
Aminorex (1585)............................ I
Gamma hydroxybutyric acid (2010)........... I
Methaqualone (2565)........................ I
Ibogaine (7260)............................ I
Lysergic acid dethylamide (7315)........... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
2,5Dimethoxyamphetamine (7396)............ I
3,4Me ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21880 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-22-E6-21879

By Notice dated August 15, 2006, and published in the Federal Register on August 22, 2006, (71 FR 4894448945), American Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal and by correspondence dated June 2, 2006, to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Gamma hydroxybutyric acid (2010)........... I
Ibogaine (7260)............................ I
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
Dimethyltryptamine (7435).................. I
Dihydromorphine (9145)..................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Amobarbital (2125)......................... II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
Cocai ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21879 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-22-E6-21875

By Notice dated July 26, 2006, and published in the Federal Register on August 14, 2006, (71 FR 4651446515), Applied Science Labs, Division of Alltech Associates Inc., 2701 Carolean Industrial Drive, State College, Pennsylvania 16801, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Methcathinone (1237)....................... I
NEthylamphetamine (1475).................. I
N,NDimethylamphetamine (1480)............. I
4Methylaminorex (cis isomer) (1590)....... I
AlphaEthyltryptamine (7249)............... I
Lysergic acid diethylamide (7315).......... I
2,5dimethoxy4(n)propylthiophenethylamin I
e (2CT7) (7348).
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
4Bromo2,5dimethoxyamphetamine (7391).... I
4Bromo2,5dimethoxyphenethylamine (7392). I
4Met ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21875 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-22-E6-21878

By Notice dated August 15, 2006, and published in the Federal Register on August 22, 2006, (71 FR 4894548946), Cambrex North Brunswick, Inc., Technology Centre of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule NEthylamphetamine (1475).................. I
Tetrahydrocannabinols (7370)............... I
2,5Dimethoxyamphetamine (7396)............ I
3,4Methylenedioxyamphetamine (7400)....... I
4Methoxyamphetamine (7411)................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Pentobarbital (2270)....................... II
Phenylacetone (8501)....................... II
Hydromorphone (9150)....................... II
Hydrocodone (91 ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21878 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Importer of Controlled Substances Notice of Registration ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21882

By Notice dated August 15, 2006 and published in the Federal Register on August 22, 2006, (71 FR 48946), Cambrex North Brunswick, Inc., Technology Centre of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance to manufacture amphetamine.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and Sec. 952(a) and determined that the registration of Cambrex North Brunswick, Inc. to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cambrex North Brunswick, Inc. to ensure that the company's registration ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21882 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-22-E6-21881

By Notice dated August 15, 2006, and published in the Federal Register on August 22, 2006, (71 FR 48946), Chemic Laboratories, Inc., 480 Neponset Street, Building 7C, Canton, Massachusetts 02021, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in schedule II.

The company plans to manufacture small quantities of a cocaine derivative for distribution to its customers for the purpose of research.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chemic Laboratories, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Chemic Laboratories, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the comp ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21881 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-22-E6-21876

By Notice dated July 26, 2006, and published in the Federal Register on August 2, 2006, (71 FR 4381343814), Clariant LSM (Missouri) Inc., 2460 W. Bennett Street, or (P.O. Box 1246, zip 65801), Springfield, Missouri 65807, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Methylphenidate (1724)..................... II
Phenylacetone (8501)....................... II

Methadone intermediate (9254).............. II

The company plans to manufacture the listed controlled substances in bulk for sale to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Clariant LSM (Missouri) Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21876 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-22-E6-21870

By Notice dated August 7, 2006, and published in the Federal Register on
[[Page 77065]]
August 15, 2006, (71 FR 46921), Dade Behring Inc., 100 GBE Drive, MS514, Post Office Box 6101, Attention: RA/QS, Newark, Delaware 19714 6101, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule Tetrahydrocannabinols (7370)............... I
Benzoylecgonine (9180)..................... II

Morphine (9300)............................ II

The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator/ controls for DEA exempt products.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Dade Behring Inc. to manufacture the listed basic classes of controlled s ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21870 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-22-E6-21871

By Notice dated August 7, 2006, and published in the Federal Register on August 15, 2006, (71 FR 46921), Dade Behring Inc., Regulatory Affairs, Quality Systems, 20400 Mariani Avenue, Cupertino, California 95014, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule Tetrahydrocannabinols (7370)............... I
Benzoylecgonine (9180)..................... II

Morphine (9300)............................ II

The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator/ controls for DEA exempt products.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Dade Behring Inc. to manufacture the listed basic classes of controlled substances is cons ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21871 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances Notice of Application]]> http://thefederalregister.com/d.p/2006-12-22-E6-21884

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 15, 2006, Johnson Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Remifentanil (9739), a basic class of controlled substance listed in schedule II.

The company plans on producing this item for sale to its customers, who are final dosage manufacturers.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DE ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21884 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Application]]> http://thefederalregister.com/d.p/2006-12-22-E6-21896

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 31, 2006, Johnson Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of 14Hydroxymorphinone (9654), a basic class of controlled substance listed in schedule II.

The company plans to manufacture the listed controlled substances in bulk as an intermediate for use in the production of another controlled substance.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR Sec. 1301.33(a).

Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enf ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21896 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Importer of Controlled Substances Notice of Registration ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21895

By Notice dated July 19, 2006, and published in the Federal Register on July 26, 2006, (71 FR 42417), Meridian Medical Technologies, 255 Hermelin Drive, St. Louis, Missouri 63144, made application to the Drug Enforcement Administration (DEA) to be registered as an importer of Morphine (9300), a basic class of controlled substance listed in schedule II.

The company plans to import products for research experimentation or clinical use and analytical testing.

One objection was received; however, it has subsequently been withdrawn. DEA has considered the factors in 21 U.S.C. Sec. 823(a) and Sec. 952(a) and determined that the registration of Meridian Medical Technologies to import the basic class of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Meridian Medical Technologies to ensure that the company's registration is con ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21895 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances Notice of Application]]> http://thefederalregister.com/d.p/2006-12-22-E6-21886

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 07, 2006, Organichem Corporation, 33 Riverside Avenue, Rensselaer, New York 12144, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Pentobarbital (2270)....................... II
Hydrocodone (9193)......................... II
Meperidine(9230)........................... II
Dextropropoxyphene (9273).................. II

Fentanyl (9801)............................ II

The company plans to manufacture bulk controlled substances for use in product development and for distribution to its customers. In reference to ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21886 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-22-E6-21873

By Notice dated July 25, 2006, and published in the Federal Register on July 31, 2006, (71 FR 43211), Penick Corporation, 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Ecgonine (9180)............................ II
Hydrocodone (9193)......................... II
Morphine (9300)............................ II
Thebaine (9333)............................ II

Oxymorphone (9652)......................... II

The company plans to manufacture the listed controlled substances as bulk controlled substance intermediat ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21873 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-22-E6-21872

By Notice dated August 15, 2006, and published in the Federal Register on August 22, 2006, (71 FR 4894748948), Research Triangle Institute, Kenneth H. Davis, Jr., Hermann Building, P.O. Box 12194, East Institute Drive, Research Triangle, North Carolina 27709, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Marihuana (7360)........................... I

Cocaine (9041)............................. II

The Institute will manufacture small quantities of cocaine and marihuana derivatives for use by their customers in analytical kits, reagents, and reference standards as directed by NIDA.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Research Triangle Institute to manufacture the listed basic classes o ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21872 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-22-E6-21877

By Notice dated August 7, 2006, and published in the Federal Register on August 15, 2006, (71 FR 46922), Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Tetrahydrocannabinols (7370)............... I
Methylphenidate (1724)..................... II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Thebaine (9333)............................ II
Noroxymorphone (9668)...................... II

Fentanyl (9801)............................ II

The company plans to manufacture the listed controlled substances in bulk for conversion and sale ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21877 Fri, Dec 22 2006 11:00:00 GMT <![CDATA[ Solicitation for a Cooperative Agreement--Transition From Jail to the Community (TJC)]]> http://thefederalregister.com/d.p/2006-12-22-E6-21978

An 18month cooperative agreement award will be made to an organization that will help NIC design a jail/community transition model that will enhance the likelihood that persons released from jails do not commit crimes following release. Ultimately, the transition model will be implemented in a limited number of localities, the impact will be evaluated and knowledge will be shared broadly about what has been learned through focused assistance to those jurisdictions. During the initial award ]]> http://thefederalregister.com/d.p/2006-12-22-E6-21978 Fri, Dec 22 2006 11:00:00 GMT